• About us
• Contact

Advertisement

Organisation › Details

Vibalogics GmbH

Vibalogics is a specialized global Contract Development and Manufacturing Organization (CDMO) offering process and analytical development, manufacturing, testing and fill-finish services to innovators developing transformational virotherapy products. From its headquarters and commercial facility in Boxborough, MA, USA and operations in Cuxhaven, Germany, Vibalogics supports its customers in the development and commercialization of oncolytic viruses, viral vectors for gene therapy and viral vaccines. *

 

	Start	2002-01-01 established
	Group	Recipharm (Group)
	Industry	contract manufacturing (biologicals)
	Industry 2	viral vector_o
	Person	Hochuli, Tom (Vibalogics 202009– CEO before Lonza Houston)
	Region	Cuxhaven
	Country	Germany
	Street	2 Zeppelinstr.
	City	27472 Cuxhaven
	Tel	+49-4721-565-400
		Address record changed: 2022-10-02
Basic data	Employees	B: 11 to 50 (2019-05-29)
		* Document for »About Section«: Recipharm AB. (2/18/22). "Press Release: Recipharm Expands Its Advanced Therapy Medicinal Products (ATMPs) Offering into Virotherapies with the Acquisition of Vibalogics".
		Record changed: 2023-12-30

Advertisement

More documents for Recipharm (Group)

• [1] Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024"....
• [2] Recipharm AB. (4/11/22). "Press Release: Recipharm Completes US Biologics Acquisitions"....
• [3] Vibalogics GmbH. (2/18/22). "Press Release: Vibalogics Acquired by Top Global CDMO Recipharm AB"....
• [4] Recipharm AB. (2/18/22). "Press Release: Recipharm Expands Its Advanced Therapy Medicinal Products (ATMPs) Offering into Virotherapies with the Acquisition of Vibalogics"....
• [5] Recipharm AB. (2/18/22). "Press Release: Recipharm Acquires Arranta Bio, a CDMO Leader in Advanced Therapy Medicinal Products (ATMPs), to Expand Its Biologics Offering in the US"....
• [6] Recipharm AB. (2/1/22). "Press Release: Recipharm Acquires GenIbet to Bolster Biologics Offering"....
• [7] Vibalogics GmbH. (9/8/20). "Press Release: Vibalogics Appoints Global CEO to Lead U.S. Expansion"....
• [8] Vibalogics GmbH. (5/29/19). "Press Release: Ampersand Capital Partners to Acquire Vibalogics GmbH". Cuxhaven & Wellesley, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.